Albumin supplementation in the critically ill. A prospective, randomized trial

E. F. Foley, B. C. Borlase, W. H. Dzik, B. R. Bistrian and P. N. Benotti
Department of Surgery, Harvard University Medical School, New England Deaconess Hospital, Boston, Mass.

Albumin replacement to correct hypoalbuminemia in critically ill patients has been controversial. This study was a prospective, randomized trial of 25% albumin administration in 40 hypoalbuminemic (serum albumin, less than 25 g/L [2.5 g/dL]), critically ill patients. The treatment group (18 patients) received 25% albumin supplementation to achieve and maintain serum albumin levels of 25 g/L (2.5 g/dL) or greater, while the nontreatment group (22 patients) received no concentrated albumin. There was no clinical benefit from albumin therapy when assessing mortality (39% vs 27%, treatment vs control) or major complication rate (89% vs 77% of patients). There were also no significant differences in length of hospital stay, intensive care unit stay, ventilator dependence, or tolerance of enteral feeding, despite significant elevations of albumin in the treatment group. The costly use of exogenous albumin as treatment for hypoalbuminemia in this patient population does not appear to be justified.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Albumin administration in the management of neonatal hypoalbuminaemia
Morris and Molloy
Arch. Dis. Child. Fetal Neonatal Ed. 2008;93:F326-F326.
FULL TEXT  

Evidence-based Colloid Use in the Critically Ill: American Thoracic Society Consensus Statement
Am. J. Respir. Crit. Care Med. 2004;170:1247-1259.
FULL TEXT  

Hypoalbuminaemia in critically ill children: incidence, prognosis, and influence on the anion gap
Durward et al.
Arch. Dis. Child. 2003;88:419-422.
ABSTRACT | FULL TEXT  

Patient Survival after Human Albumin Administration: A Meta-Analysis of Randomized, Controlled Trials
Wilkes and Navickis
ANN INTERN MED 2001;135:149-164.
ABSTRACT | FULL TEXT  

The role of albumin in critical illness
Nicholson et al.
Br J Anaesth 2000;85:599-610.
ABSTRACT | FULL TEXT  

The Good, the Bad, and the Ugly: Should We Completely Banish Human Albumin from Our Intensive Care Units?
Boldt
Anesth. Analg. 2000;91:887-895.
ABSTRACT | FULL TEXT  

Human albumin administration in critically ill patients: systematic review of randomised controlled trials • Why albumin may not work
Reviewers and Reviewers
BMJ 1998;317:235-240.
ABSTRACT | FULL TEXT  

The Therapeutic Use of Albumin
Hastings and Wolf
Arch Fam Med 1992;1:281-287.
ABSTRACT  

Invited Review: Nutrition in the Neurologically Injured Patient
Ott and Young
Nutr Clin Pract 1991;6:223-229.
ABSTRACT